Nitto Denko Avecia Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
607
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
2
Nitto Denko Avecia General Information
Description
Manufacturer of oligonucleotide therapeutics molecules intended for the treatment of diseases. The company offers preclinical manufacturing, analytical development, process development, drug substance manufacturing, process performance optimization, quality control and stability services, thereby providing comprehensive solutions for oligonucleotide production.
Contact Information
Website
www.avecia.com(Operating Subsidiary)
Corporate Office
- 125 Fortune Boulevard
- Milford, MA 01757
- United States
Corporate Office
- 125 Fortune Boulevard
- Milford, MA 01757
- United States
Nitto Denko Avecia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nitto Denko Avecia Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nitto Denko Avecia Patents
Nitto Denko Avecia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12030030-B1 | Modular synthesizer assembly | Active | 12-Feb-2020 | ||
| EP-4089099-A1 | Nucleic acid synthesis method using segment-type amidite | Pending | 08-Jan-2020 | ||
| EP-4089099-A4 | Nucleic acid synthesis method using segment-type amidite | Pending | 08-Jan-2020 | ||
| US-20240391945-A1 | Nucleic acid synthesis method using segment-type amidite | Pending | 08-Jan-2020 | ||
| JP-7657736-B2 | Nucleic acid synthesis using segmented amidites | Active | 08-Jan-2020 | C07H21/00 |
Nitto Denko Avecia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nitto Denko Avecia Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nitto Denko Avecia Investments & Acquisitions (2)
Nitto Denko Avecia’s most recent deal was a Merger/Acquisition with Irvine Pharmaceutical Services. The deal was made on 11-Oct-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Irvine Pharmaceutical Services | 11-Oct-2016 | Merger/Acquisition | Pharmaceuticals | ||
| Synthon Chiragenics (Fine Chemicals business) | 14-Feb-2003 | Buyout/LBO | Biotechnology |
Nitto Denko Avecia FAQs
-
When was Nitto Denko Avecia founded?
Nitto Denko Avecia was founded in 1999.
-
Where is Nitto Denko Avecia headquartered?
Nitto Denko Avecia is headquartered in Milford, MA.
-
What is the size of Nitto Denko Avecia?
Nitto Denko Avecia has 607 total employees.
-
What industry is Nitto Denko Avecia in?
Nitto Denko Avecia’s primary industry is Biotechnology.
-
Is Nitto Denko Avecia a private or public company?
Nitto Denko Avecia is a Private company.
-
What is Nitto Denko Avecia’s current revenue?
The current revenue for Nitto Denko Avecia is .
-
Who are Nitto Denko Avecia’s investors?
AstraZeneca, Cinven, and Investcorp have invested in Nitto Denko Avecia.
-
When was Nitto Denko Avecia acquired?
Nitto Denko Avecia was acquired on 03-Feb-2011.
-
Who acquired Nitto Denko Avecia?
Nitto Denko Avecia was acquired by Nitto Denko.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
